Relationship between Some Acute Phase Reactants and the Bath Ankylosing Spondylitis Disease Activity Index in Patients with Ankylosing Spondylitis

Southern Medical Journal

Volumn 97, Issue 4, 2004, Pages 350-353

  Yildirim, Kadir ^a,b   Erdal, Akin ^a   Karatay, Saliha ^a   Melikoǧlu, Meltem Alkan ^a   Uǧur, Mahir ^a   Şenel, Kazim ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Acute phase reactants; Ankylosing spondylitis; Disease activity index

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; HAPTOGLOBIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; MALE; MORNING STIFFNESS; OUTPATIENT; PAIN ASSESSMENT; STATISTICAL SIGNIFICANCE; UNITED STATES; VISUAL ANALOG SCALE;

ADULT; BETA 2-MICROGLOBULIN; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FATIGUE; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 1842680781     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000066946.56322.3C     Document Type: Article

References (23)

1. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.
2. Arnett FC. Seronegative spondylarthropathies. Bull Rheum Dis 1987;37:1-12.
3. El-Khoury GY, Kathol MH, Brandser EA. Seronegative spondyloarthropathies. Radiol Clin North Am 1996;34:343-357.
4. Hanson CA, Shagrin JW, Duncan H. Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop 1971;74:59-64.
5. Pedrazzi AH. Acute phase proteins: clinical and laboratory diagnosis - A review. Ann Pharm Fr 1998;56:108-114.
6. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
7. 2-globulin occurring in human biological fluids. J Biol Chem 1968;243:4095-4103.
8. 2-microglobulin. J Exp Med 1973;138:1608-1612.
9. Raynes JG, Eagling S, McAdam KP. Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin Exp Immunol 1991;83:488-491.
10. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-2291.
11. van Leeuwen MA, van Rijswijk MH. Acute phase proteins in the monitoring of inflammatory disorders. Baillieres Clin Rheumatol 1994;8:531-552.
12. Lange U, Boss B, Teichmann J, et al. Serum amyloid A: an indicator of inflammation in ankylosing spondylitis. Rheumatol Int 2000;19:119-122.
13. Nashel DJ, Petrone DL, Ulmer CC, et al. C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome, J Rheumatol 1986;13:364-367.
14. Dougados M, Gueguen A, Nakache JP, et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 1999;26:971-974.
15. Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-984.
16. Sheehan NJ, Slavin BM, Donovan MP, et al. Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 1986;25:171-174.
17. Young B, Gleeson M, Cripps AW. C-reactive protein: A critical review. Pathology 1991;23:118-124.
18. Gewurz H, Mold C, Siegel J, et al. C-reactive protein and the acute phase response. Adv Intern Med 1982;27:345-372.
19. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992;35:982-984 (letter).
20. Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician 1999;60:1443-1450.
21. Lascari AD. The erythrocyte sedimentation rate. Pediatr Clin North Am 1972;19:1113-1121.
22. Pepys MB. The acute-phase response and C-reactive protein, in Weatherall DJ, Ledingham JGG, Warrell DA (eds): Oxford Textbook of Medicine. New York, Oxford University Press, 1996, vol 2, ed 3, pp 1527-1533.
23. Rossbacher J, Wagner L, Pasternack MS. Inhibitory effect of haptoglobin on granulocyte chemotaxis, phagocytosis and bactericidal activity. Scand J Immunol 1999;50:399-404.